Role of FDG-PET in oncological surgery

Fluorine-18 fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) allows in vivo analysis of tissue metabolic activity. Based on the observation that most malignant tumors display a higher metabolic activity than benign tissues, [18F]FDG-PET offers an interesting option for the diagnosis of...

Full description

Saved in:
Bibliographic Details
Published inChirurg Vol. 72; no. 5; pp. 528 - 536
Main Authors Schürmann, G, Franzius, C, Twelker, L, Senninger, N, Schober, O
Format Journal Article
LanguageGerman
Published Germany 01.05.2001
Subjects
Blood Glucose - metabolism
Energy Metabolism - physiology
Fluorodeoxyglucose F18
Humans
Neoplasm Recurrence, Local - diagnostic imaging
Neoplasm Recurrence, Local - physiopathology
Neoplasm Recurrence, Local - surgery
Neoplasms - diagnostic imaging
Neoplasms - physiopathology
Neoplasms - surgery
Predictive Value of Tests
Reoperation
Tomography, Emission-Computed
Online AccessGet full text

Cover

More Information
Summary:Fluorine-18 fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) allows in vivo analysis of tissue metabolic activity. Based on the observation that most malignant tumors display a higher metabolic activity than benign tissues, [18F]FDG-PET offers an interesting option for the diagnosis of primary and recurrent malignant tumors. For the oncological surgeon [18F]FDG-PET is particularly helpful for the diagnosis of tumors of the pancreas, colorectum, lung and esophagus. This short review describes the biological basis of [18F]FDG-PET and gives a critical discussion of its role in oncological surgery.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0009-4722